Japan, a U.S. ally that had angered China on Taiwan, found the message worrying.
Author: admin
President Trump addresses the nation following shooting of two National Guardsmen in DC
President Donald Trump says the alleged shooter of two National Guard members in Washington, D.C., entered the United States from Afghanistan in 2021 and
Trade war update: Carney’s Liberals to announce steel, lumber protections, sources say
Multiple senior government sources confirmed to CTV News that Mark Carney will announce measures on Wednesday to protect both the steel and softwood lumber
Trump backs right-wing candidate Nasry Asfura in Honduras election
US President Donald Trump on Wednesday endorsed right-wing candidate Nasry Asfura in the upcoming presidential election in Honduras, saying the two can work together
Trump disinvites South Africa from 2026 G20 summit
The two nations have suffered a mired relationship as Trump continues to deplore South Africa for what he says is ongoing persecution of South
2 Dividend Stocks to Buy Now for Big Payout Growth Ahead
Merck and Qualcomm combine strong cash flow with steady dividend growth, signaling potential for meaningful payout increases ahead.
Stocks climb on hopes for lower interest rates as Dow rallies 660 points
Stocks got a boost from easing yields in the bond market. Lower interest rates can cover up many sins in financial markets, including prices
Stocks buoyed by rate cut expectations, sterling choppy on UK budget surprise
Global stocks rallied for a fourth straight day on Wednesday as expectations for a U.S. Federal Reserve rate cut remained elevated, while sterling was
SA Quant ranks Goldman’s large-cap stocks with largest short interest
Goldman Sachs analysts last week identified 50 large-cap stocks with the highest short interest as a percentage of market cap, a list that was
Pfizer : FDA Oks PADCEV + Keytruda Combo For Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
(RTTNews) – Pfizer Inc. (PFE) and Astellas Pharma Inc. (ALPMY, 4503.T) announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV (enfortumab